NASDAQ · CPAA
Conyers Park III Acquisition Corp.
$10.30+$0.01 (+0.1%)
Conyers Park III Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 2.88% below the high.
Loading market information…
AMEX · VHAQ · USD
Stock price, earnings
Quote as of Jan 30, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Viveon Health Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 15.97% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Viveon Health Acquisition Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Viveon Health Acquisition Corp. presently lacks substantial ongoing operations. The company's main goal is to finalize a strategic transaction, which could include a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or a similar business combination, involving one or more companies in the North American healthcare industry. This firm was established in 2020 and is headquartered in Norcross, Georgia.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:56 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.30+$0.01 (+0.1%)
Conyers Park III Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 2.88% below the high.
$25.97+$12.27 (+89.56%)
Digital Transformation Opportunities Corp.’s quoted price sits in the upper half of its reported 52-week range, 34.42% below the high.
$10.35-$0.01 (-0.1%)
Forum Merger IV Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.48% below the high.
$11.07-$0.93 (-7.75%)
10X Capital Venture Acquisition Corp. III’s quoted price sits in the lower half of its reported 52-week range, 14.78% below the high.
$10.58-$0.06 (-0.53%)
Schultze Special Purpose Acquisition Corp. II’s quoted price sits in the lower half of its reported 52-week range, 10.34% below the high.
$10.80+$0.01 (+0.05%)
Magnum Opus Acquisition Limited’s quoted price sits in the upper half of its reported 52-week range, 3.87% below the high.
$8.11+$1.20 (+17.37%)
LAMF Global Ventures Corp. I’s quoted price sits in the lower half of its reported 52-week range, 62.28% below the high.
$11.90+$3.40 (+40.0%)
LatAmGrowth SPAC’s quoted price sits in the upper half of its reported 52-week range, 23.13% below the high.
